Gilead shares rise on report of AstraZeneca's interest in megamerger
- Editor Desk
- Jun 8, 2020
- 1 min read
Shares of Gilead Sciences Inc rose as much as 3% on Monday after a report said the U.S. drugmaker had been approached by Britain’s AstraZeneca for a possible merger to form one of the world’s largest drug companies.
AstraZeneca contacted Gilead last month but the U.S. company, which is testing its drug remdesivir as a COVID-19 treatment, was not interested in combining with another big drugmaker, Bloomberg reported.
Gilead’s shares, which have risen about 18% this year through Friday’s close, pared some of their premarket gains after CNBC reported citing sources that the companies were not in active talks.
Squarefoot Flooring has been a retail leader in the distribution of Flooring products for 10 Years. We currently provide services in Mississauga, Toronto, Brampton, Oakville, Markham, Richmond Hill. Stoney Creek, Niagara Falls. Hamilton, Ancaster, Burlington, Kitchener, Guelph, Sudbury, Pickering, Ajax, Whitby, Oshawa. We excel in providing a quality product in order to make your dream place a reality and have won the title for “Mississauga’s 2019 favorite business. With over 9000+ options for flooring we bring you the largest variety of styles, materials and colors to select only markham flooring the best.